Myasthenia gravis and tumor necrosis factor β polymorphisms: Linkage disequilibrium but no association beyond HLA-B8

Journal of Neuroimmunology

Volumn 90, Issue 2, 1998, Pages 187-191

  Manz, Markus G ^a   Melms, Arthur ^a   Sommer, Norbert ^a   Müller, Claudia A ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

HLA association; Myasthenia gravis; TNF polymorphisms

Indexed keywords

HLA B8 ANTIGEN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

ADULT; AGED; ALLELES; FEMALE; HLA-B8 ANTIGEN; HLA-DR ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; MYASTHENIA GRAVIS;

EID: 0032191615     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00144-1     Document Type: Article

References (25)

1. Badenhoop K., Schwarz G., Schleusener H., Weetman A.P., Recks S., Peters H., Bottazzo G.F., Usadel K.H. Tumor necrosis factor b gene polymorphisms in graves disease. J. Clin. Endocrinol. Metab. 74:1992;287-291.
2. Bettinotti M.P., Hartung K., Deicher H., Messer G., Keller E., Weiss E.H., Albert E.D. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFb-MHC haplotypes. Immunogenetics. 37:1993;449-454.
3. Choo S.Y., Spies T., Strominger J.L., Hansen J.A. Polymorphism in the tumor necrosis factor gene: association with HLA-B and DR haplotypes. Hum. Immunol. 23:1988;86.
4. Compston D.A.S., Vincent A., Newsom-Davis J., Batchelor J.R. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain. 103:1980;579-601.
5. Dawkins R.L., Christiansen F.T., Kay P.H., Garlepp M., McCluskey J., Hollingsworth P.N., Zilko P.J. Disease associations with complotypes, supratypes and haplotypes. Immunol. Rev. 70:1983;5-22.
6. Dawkins R.L., Leaver A., Cameron P.U., Martin E., Kay P.H., Christiansen F.T. Some disease-associated ancrestal haplotypes carry a polymorphism of TNF. Hum. Immunol. 26:1989;91-97.
7. Degli-Esposti M.A., Andreas A., Christiansen F.T., Schalke B., Albert E., Dawkins R.L. An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics. 35:1992;355-364.
8. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330:1994;1797-1810.
9. Ferencik S., Lindemann M., Horsthemke B., Grosse-Wilde H. A new restriction fragment length polymorphism of the human TNFb gene detected by AspHI digest. Eur. J. Immunogen. 19:1992;425-430.
10. Fugger L., Morling N., Ryder L.P., Georgsen J., Jakobsen B.K., Svejgaard A., Andersen V., Oxholm P., Pedersen F.K., Friis J., Halberg P. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNFa) region in four autoimmune diseases. Tissue Antigens. 34:1989;17-22.
11. Fugger L., Morling N., Sandberg-Wollheim M., Ryder L.P., Svejgaard A. Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis. J. Neuroimmunol. 27:1990;85-88.
12. Lino, M.M., Zelano, G., Batocchi, A.P., Evoli, A., Tonali, P., 1997. Tumor necrosis factor gene polymorphisms in thymoma and non-thymoma myasthenia gravis. In: Marx, A., Müller-Hermelink, H.-K. (Eds.), Epithelial tumors of the thymus. Plenum, New York, pp. 261-264.
13. Messer G., Spengler U., Jung M.C., Honold G., Blömer K., Pape G.R., Riethmüller G., Weiss E.H. Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNFb gene correlates with a variant amino acid in position 26 and a reduced level of TNFb production. J. Exp. Med. 173:1991;209-219.
14. Messer G., Spengler U., Jung M.C., Honold G., Eisenburg J., Scholz S., Albert E.D., Pape G.R., Riethmüller G., Weiss E.H. Allelic variation in the TNFb gene does not explain the low TNFb response in patients with primary biliary cirrhosis. Scand. J. Immunol. 34:1991;735-740.
15. Nedwin G.E., Naylor S.L., Sakaguchi A.Y., Smith D., Jarrett-Nedwin J., Pennica D., Goeddel D.V., Gray P.W. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 13:1985;6361-6373.
16. Partanen J., Koskimies S. Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumor necrosis factor b) gene. Scand. J. Immunol. 28:1988;313-316.
17. Pirskanen R. Genetic associations between myasthenia gravis and the HLA system. J. Neurol. Neurosurg. Psychiatry. 39:1976;23-33.
18. Pociot F., Molvig J., Wogensen L., Worsaae H., Dalboge H., Baek L., Nerup J. A tumor necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand. J. Immunol. 33:1991;37-49.
19. Pociot F., Briant L., Jongeneel C.V., Mölvig J., Worsaae H., Abbal M., Thomsen M., Nerup J., Cambon-Thomsen A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNFa and TNFb by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23:1993;224-231.
20. Pujol-Borrell R., Todd I., Doshi M., Bottazzo G.F., Sutton R., Gray D., Adolf G.R., Feldmann M. HLA class II induction in human islet cells by interferon-g plus tumor necrosis factor or lymphotoxin. Nature. 326:1987;304-306.
21. Roth M.-P., Nogueira L., Coppin H., Clanet M., Clayton J., Cambon-Thomsen A. Tumor necrosis factor polymorphisms in multiple sclerosis: no additional association independent of HLA. J. Neuroimmunol. 51:1994;93-99.
22. Verjans G., van der Linden S.M., van Eys G.J.J.M., de Wal L.P., Kijlstra A. Restriction fragment length polymorphism of the tumor necrosis factor region in patients with ankylosing spondylitis. Arthritis Rheum. 34:1991;486-489.
23. Webb G.C., Chaplin D.D. Genetic variability at the human tumor necrosis factor loci. J. Immunol. 145:1990;1278-1285.
24. Wingerchuk D., Liu Q., Sobell J., Sommer S., Weinshenker B.G. A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis. Neurology. 49:1997;626-628.
25. Wong G.H., Goeddel D.V. Tumor necrosis factor alpha and beta inhibit virus replication and synergize with interferons. Nature. 323:1986;819-822.